Foreign expansion of hypertension/hyperlipidemia complexes
Domestic hypertension and hyperlipidemia complexes have aggressively knocked on the door of foreign markets. They have either been directly conducted on foreign clinical trials or been jointly developed with global big pharmaceuticals.
On the 9th, Boryung Pharm announced approval for a Phase 1 ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
